|
|
|
Insider
Information: |
Bishop John E |
Relationship: |
SVP, Chief Technology ... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
157,253 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,252,637 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
157,253 |
|
|
Total
Value |
$8,252,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Pharmaceuti... |
2016-05-19 |
157,253 |
2006-02-17 |
0 |
Premium* |
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Technology ... |
2022-10-14 |
0 |
2021-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2008-08-16 |
4 |
AS |
$12.91 |
$516 |
D/D |
(40) |
38,845 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2013-08-27 |
4 |
AS |
$15.00 |
$960 |
D/D |
(64) |
99,865 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2013-11-26 |
4 |
AS |
$18.09 |
$1,158 |
D/D |
(64) |
93,780 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-03-04 |
4 |
AS |
$14.41 |
$922 |
D/D |
(64) |
111,069 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-05-27 |
4 |
AS |
$12.24 |
$783 |
D/D |
(64) |
110,215 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-08-27 |
4 |
AS |
$12.00 |
$768 |
D/D |
(64) |
109,360 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-11-26 |
4 |
AS |
$11.60 |
$742 |
D/D |
(64) |
108,505 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2015-02-25 |
4 |
AS |
$13.20 |
$845 |
D/D |
(64) |
124,943 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-05-23 |
4 |
S |
$12.09 |
$798 |
D/D |
(66) |
110,279 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2015-11-18 |
4 |
AS |
$17.70 |
$1,345 |
D/D |
(76) |
94,642 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2015-08-21 |
4 |
AS |
$20.01 |
$1,581 |
D/D |
(79) |
95,030 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2015-11-23 |
4 |
AS |
$17.91 |
$1,433 |
D/D |
(80) |
93,520 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2016-02-19 |
4 |
AS |
$9.61 |
$817 |
D/D |
(85) |
110,263 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2016-02-23 |
4 |
AS |
$9.80 |
$1,000 |
D/D |
(102) |
107,086 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2015-02-23 |
4 |
AS |
$12.93 |
$1,668 |
D/D |
(129) |
125,218 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-11-24 |
4 |
AS |
$11.53 |
$1,557 |
D/D |
(135) |
108,780 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-02-27 |
4 |
AS |
$17.49 |
$3,690 |
D/D |
(211) |
111,133 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-11-25 |
4 |
AS |
$11.67 |
$2,462 |
D/D |
(211) |
108,569 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2015-02-24 |
4 |
AS |
$13.56 |
$2,861 |
D/D |
(211) |
125,007 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2013-11-18 |
4 |
AS |
$17.19 |
$3,679 |
D/D |
(214) |
94,404 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2013-08-20 |
4 |
AS |
$14.47 |
$3,140 |
D/D |
(217) |
100,273 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2013-11-19 |
4 |
AS |
$17.17 |
$3,726 |
D/D |
(217) |
94,187 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-05-15 |
4 |
AS |
$11.09 |
$2,407 |
D/D |
(217) |
110,852 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-08-15 |
4 |
AS |
$11.75 |
$2,550 |
D/D |
(217) |
109,998 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
|
2014-11-17 |
4 |
AS |
$10.64 |
$2,309 |
D/D |
(217) |
109,143 |
0 |
- |
|
167 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|